We are live on ! Find out more
Man Group

Man Group Portfolio holdings

AUM $55.1B
1-Year Est. Return 24.23%
This Fund
S&P 500
This Quarter Est. Return
+4.91%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
AUM
$27.7B
AUM Growth
+$1.31B
Cap. Flow
-$62M
Cap. Flow %
-0.22%
Top 10 Hldgs %
10.22%
Holding
2,128
New
178
Increased
803
Reduced
775
Closed
264

Top Buys

Rank Stock Value
1
AMP icon
Ameriprise Financial
AMP
+$136M
2
ABBV icon
AbbVie
ABBV
+$129M
3
TSM icon
TSMC
TSM
+$126M
4
BABA icon
Alibaba
BABA
+$121M
5
NXPI icon
NXP Semiconductors
NXPI
+$121M

Sector Composition

Rank Sector Weight
1 Financials 16.57%
2 Technology 15.79%
3 Healthcare 13.34%
4 Consumer Discretionary 12.03%
5 Industrials 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTRS icon
926
Northern Trust
NTRS
$22.2B
$4.64M 0.02%
51,546
+35,903
+230% +$3.31M
AJRD
927
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$4.63M 0.02%
+103,325
New +$3.85M
SFNC icon
928
Simmons First National
SFNC
$3.35B
$4.61M 0.02%
+198,336
New +$4.83M
INGN icon
929
Inogen
INGN
$167M
$4.61M 0.02%
68,979
+39,556
+134% +$3.01M
TDOC icon
930
Teladoc Health
TDOC
$1.58B
$4.58M 0.02%
69,023
-13,812
-17% -$805K
JBHT icon
931
JB Hunt Transport Services
JBHT
$27.1B
$4.54M 0.02%
49,715
-11,473
-19% -$1.08M
WOR icon
932
Worthington Enterprises
WOR
$2.76B
$4.54M 0.02%
183,007
+29,619
+19% +$695K
RMD icon
933
ResMed
RMD
$28.3B
$4.53M 0.02%
37,081
-35,346
-49% -$3.92M
AKBA icon
934
Akebia Therapeutics
AKBA
$327M
$4.52M 0.02%
934,650
+346,242
+59% +$1.97M
MIDD icon
935
Middleby
MIDD
$6.05B
$4.51M 0.02%
33,259
+23,568
+243% +$3.17M
HUBG icon
936
HUB Group
HUBG
$3.01B
$4.51M 0.02%
214,738
+148,480
+224% +$3.12M
ACRS icon
937
Aclaris Therapeutics
ACRS
$730M
$4.51M 0.02%
2,057,936
+872,408
+74% +$4.76M
JNPR
938
DELISTED
Juniper Networks
JNPR
$4.51M 0.02%
169,196
-121,179
-42% -$3.24M
RNST icon
939
Renasant Corp
RNST
$4.01B
$4.5M 0.02%
125,157
-7,676
-6% -$270K
MTCH icon
940
Match Group
MTCH
$8.84B
$4.5M 0.02%
66,819
-25,436
-28% -$1.66M
BIO icon
941
Bio-Rad Laboratories Class A
BIO
$8.42B
$4.49M 0.02%
14,369
-12,553
-47% -$3.76M
WD icon
942
Walker & Dunlop
WD
$1.65B
$4.49M 0.02%
84,400
-46,759
-36% -$2.48M
PPG icon
943
PPG Industries
PPG
$25.9B
$4.49M 0.02%
38,469
+7,148
+23% +$815K
SD icon
944
SandRidge Energy
SD
$510M
$4.49M 0.02%
648,881
+33,145
+5% +$254K
ETRN
945
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$4.47M 0.02%
+226,879
New +$4.71M
ISRG icon
946
Intuitive Surgical
ISRG
$121B
$4.43M 0.02%
25,359
-46,734
-65% -$8.01M
KAMN
947
DELISTED
Kaman Corp
KAMN
$4.43M 0.02%
69,497
+33,261
+92% +$1.99M
CADE
948
DELISTED
Cadence Bancorporation
CADE
$4.43M 0.02%
212,799
-50,570
-19% -$1.04M
TRP icon
949
TC Energy
TRP
$73.5B
$4.42M 0.02%
89,291
+46,919
+111% +$2.25M
EBS icon
950
Emergent Biosolutions
EBS
$375M
$4.42M 0.02%
91,478
-365,819
-80% -$17.5M

Similar funds

Man Group's Q2 2019 Portfolio in Review

As of Q2 2019, Man Group held 2,128 positions worth $27.7B, up 5% from $26.4B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Man Group's Q2 2019 filing shows 178 new, 803 increased, 775 reduced and 264 closed positions. Its largest new stake was Americold: 723,300 shares worth $23.4M. The largest sale was Rogers Communications, an estimated $125M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

  • Man Group's largest Q2 2019 buy was Americold: 723,300 shares worth $23.4M.
  • Man Group added most to Ameriprise Financial in Q2 2019, an estimated $136M increase.
  • Man Group's biggest Q2 2019 reduction was Rogers Communications, cutting an estimated $125M.
  • Man Group fully exited Baidu in Q2 2019, selling an estimated $61.7M.
  • Man Group's ten largest holdings make up 10% of its $27.7B portfolio in Q2 2019.
  • Man Group opened 178 new positions and closed 264 in Q2 2019.
  • Man Group's portfolio value rose 5% quarter-over-quarter to $27.7B.

Based on Man Group's 13F filing for Q2 2019, filed 14 Aug 2019.